Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: Update of the Memorial Sloan-Kettering experience Academic Article uri icon

Overview

MeSH Major

  • Nasopharyngeal Neoplasms
  • Radiotherapy, Intensity-Modulated

abstract

  • The pattern of primary site failure within the target volume suggests locally advanced T stage disease may require a higher biologic dose to gross tumor. Rates of severe (Grade 3-4) ototoxicity and xerostomia are low with IMRT as a result of normal-tissue protection. Distant metastases are now the dominant form of failure, emphasizing the need for improved systemic therapy.

publication date

  • January 2006

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2005.03.057

PubMed ID

  • 15936155

Additional Document Info

start page

  • 57

end page

  • 62

volume

  • 64

number

  • 1